Publication | Open Access

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Esophageal CancerGastrointestinal OncologyMedicinePrevious ChemotherapyNivolumab Versus ChemotherapyPathologyCancer TreatmentOncologyRadiation OncologyMolecular Oncology